These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39212374)

  • 61. Tricuspid Annuloplasty for Tricuspid Regurgitation Secondary to Left-Sided Heart Valve Disease: Immediate Outcomes and Risk Factors for Late Failure.
    Gatti G; Dell'Angela L; Morosin M; Maschietto L; Pinamonti B; Forti G; Benussi B; Nicolosi GL; Sinagra G; Pappalardo A
    Can J Cardiol; 2016 Jun; 32(6):760-6. PubMed ID: 26777269
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Subtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosis.
    Banerjee A; Allan V; Denaxas S; Shah A; Kotecha D; Lambiase PD; Joseph J; Lund LH; Hemingway H
    Europace; 2019 Dec; 21(12):1776-1784. PubMed ID: 31408153
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation　- The Fushimi AF Registry.
    Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
    Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival.
    Minga I; Kwak E; Hussain K; Wathen L; Gaznabi S; Singh L; Macrinici V; Wang CH; Singulane C; Addetia K; Sarswat N; Slivnick J; Pursnani A
    Curr Probl Cardiol; 2024 Apr; 49(4):102417. PubMed ID: 38280494
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Valvular heart disease: the influence of changing etiology on nosology.
    Boudoulas H; Vavuranakis M; Wooley CF
    J Heart Valve Dis; 1994 Sep; 3(5):516-26. PubMed ID: 8000586
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Timing of intervention in asymptomatic patients with valvular heart disease.
    Baumgartner H; Iung B; Otto CM
    Eur Heart J; 2020 Dec; 41(45):4349-4356. PubMed ID: 32901279
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Continuous-Flow Left Ventricular Assist Devices and Valvular Heart Disease: A Comprehensive Review.
    Noly PE; Pagani FD; Noiseux N; Stulak JM; Khalpey Z; Carrier M; Maltais S
    Can J Cardiol; 2020 Feb; 36(2):244-260. PubMed ID: 32036866
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Profile of adult patients presenting for rheumatic mitral valve surgery at a tertiary academic hospital.
    Mokitimi N; van der Donck K; Moutlana H; Chakane PM
    Cardiovasc J Afr; 2021 Sep-Oct 23; 32(5):261-266. PubMed ID: 34292292
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Temporal change in repolarization parameters after surgical correction of valvular heart diseases.
    Cho MS; Seo HC; Yoon GW; Lee JS; Joo S; Nam GB
    J Electrocardiol; 2023; 79():46-52. PubMed ID: 36934492
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Valvular heart disease in the community: a European experience.
    Iung B; Baron G; Tornos P; Gohlke-Bärwolf C; Butchart EG; Vahanian A
    Curr Probl Cardiol; 2007 Nov; 32(11):609-61. PubMed ID: 17976510
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of asymptomatic valvular heart disease in the elderly population: a community-based echocardiographic study.
    Tsampasian V; Militaru C; Parasuraman SK; Loudon BL; Lowery C; Rudd A; Srinivasan J; Singh S; Dwivedi G; Mahadavan G; Dawson D; Clark A; Vassiliou VS; Frenneaux MP
    Eur Heart J Cardiovasc Imaging; 2024 Jul; 25(8):1051-1058. PubMed ID: 38925103
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pulmonary Hypertension with Valvular Heart Disease: When to Treat the Valve Disease and When to Treat the Pulmonary Hypertension.
    Martinez C; Tsugu T; Sugimoto T; Lancellotti P
    Curr Cardiol Rep; 2019 Nov; 21(12):151. PubMed ID: 31768665
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Turkish registry of heart valve disease.
    Demirbağ R; Sade LE; Aydın M; Bozkurt A; Acartürk E
    Turk Kardiyol Dern Ars; 2013 Jan; 41(1):1-10. PubMed ID: 23518931
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluating the effect of multivalvular disease on mortality after transcatheter aortic valve replacement for aortic stenosis: a meta-analysis and systematic review.
    Siddiqi TJ; Usman MS; Ahmed J; Shahid I; Ahmed W; Alkhouli M
    Future Cardiol; 2022 Apr; ():. PubMed ID: 35485390
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
    Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
    J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical implications of late mitral valve regurgitation appearance in the follow-up of heart transplantation.
    Roig E; Jacobo A; Sitges M; Vallejos I; Paré C; Pons F; Serra J; Azqueta M; Pomar JL; Pérez-Villa F
    Transplant Proc; 2007 Sep; 39(7):2379-81. PubMed ID: 17889196
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of Valvular Heart Disease on Clinical Outcomes in Sarcoidosis.
    Hussain B; Markson F; Mamas MA; Alraies C; Aggarwal V; Kumar G; Desai R; Paul TK
    Curr Probl Cardiol; 2023 Oct; 48(10):101866. PubMed ID: 37301487
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence and correlates of physiological valvular regurgitation in healthy subjects.
    Okura H; Takada Y; Yamabe A; Ozaki T; Yamagishi H; Toda I; Yoshiyama M; Yoshikawa J; Yoshida K
    Circ J; 2011; 75(11):2699-704. PubMed ID: 21881247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.